CH Biotech R&D Co., Ltd. (6534.TW) stock: key figures, P/E, revenue and dividend

Materials · Taiwan

Price
85.10 TWD
Market cap
8.75 bn TWD
P/E (2025)
18.87
P/S (2025)
4.81
Dividend yield
6.24 %
Net margin
25.49 %
Return on equity (ROE)
17.27 %
Return on assets (ROA)
12.98 %

CH Biotech R&D Co., Ltd. financials

Fiscal year20242025
Revenue1.64 bn TWD1.82 bn TWD
Gross profit1.36 bn TWD1.36 bn TWD
Operating income542.30 m TWD623.13 m TWD
EBIT607.96 m TWD623.13 m TWD
Net income476.39 m TWD463.79 m TWD
Diluted EPS – continuing operations4.61 TWD4.51 TWD

Full history since 2019, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About CH Biotech R&D Co., Ltd.

CH Biotech R&D Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of agriculture chemicals in Taiwan, the United States, and internationally. It offers fertilizers, biostimulants, and plant growth regulators; and provides biotechnology services. The company was incorporated in 2013 and is headquartered in Nantou City, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.